GCN Home > 09/25/06 issue
Substance control
DEA uses a PKI system to better better track the flow of certain drugs
By William Jackson, GCN Staff
The Drug Enforcement Administration is charged with tracking the movement of controlled substances and keeps a particularly sharp eye on so-called Schedule II drugs such as morphine and oxycodone.

The Schedule II drugs need to have more tracking, said Mike Mapes, chief of the e-commerce section of the DEA Office of Diversion Control, which sees that prescription drugs do not get diverted into illegal channels.

Tracking of wholesale sales traditionally has been done with DEA Form 222, a paper form in triplicate, imprinted with the buyers name and DEA registration numbers, which must be filled out by the buyer and supplier, and submitted to DEA.

Theyve been used forever, and there hasnt been a lot of diversion or copying because they are printed carefully on high-quality paper, Mapes said. They have worked well.

Form 222 hasnt actually been used foreverjust since 1970. But thats long enough to begin showing its age. The forms are expensive to print, and moving them back and forth between buyer and supplier takes time.

It creates a lag in the process, Mapes said.

This discourages pharmacies from making frequent small orders and results in larger stockpiles on the shelves, which can be a security problem.

E-commerce was an obvious answer to these drawbacks, and DEA has responded with the Controlled Substances Ordering System, which enables third-party electronic ordering systems to use digital certificates and e-signatures in place of the paper forms. It allows them to deal with their inventory a lot better doing it electronically, Mapes said.

A straightforward PKI system

CSOS was developed for DEA by Nortel Government Solutions Inc. of Fairfax, Va. We provided the means to allow the electronic transmission of orders, said Dick Thelen, director of Nortels public-key infrastructure center.

Nortel is the certificate authority for CSOS, enrolling individuals in the controlled-substances supply chain, and issuing and managing the X.509 certificates, which contain the private encryption keys. The same information still has to be supplied to DEA within 48 hours of a transaction for Schedule II drugs, but now it can be sent electronically rather than on paper. This means data from the electronic ordering system can be used.

The system is straightforward. A hashing algorithm is used to create an electronic digest of the electronic order, and the digest is encrypted with a private key. The recipient decrypts the digest with the senders public key and verifies that the document has not been tampered with by making another hash and comparing the two. This provides both nonrepudiation and integrity of the electronically signed document.

The impetus for the system came from industry, which saw an opportunity for greater efficiencies and cost savings by extending the use of their existing electronic ordering systems to Schedule II drugs. DEA worked with the Health Care Distribution Management Association and the National Association of Chain Drug Stores to develop system requirements.

More news on related topics: Software Applications, Health IT